Depot-specific differences in adipose tissue gene expression in lean and obese subjects.
Intra-abdominal and subcutaneous adipose tissue display important metabolic differences that underlie the association of visceral, but not subcutaneous, fat with obesity-related cardiovascular and metabolic problems. Because the molecular mechanisms contributing to these differences are not yet defined, we compared by reverse transcription-polymerase chain reaction the expression of 15 mRNAs that encode proteins of known importance in adipocyte function in paired omental and subcutaneous abdominal biopsies. No difference in mRNA expression between omental and subcutaneous adipose tissue was observed for hormone sensitive lipase, lipoprotein lipase, 6-phosphofructo-1-kinase, insulin receptor substrate 1, p85alpha regulatory subunit of phosphatidylinositol-3-kinase, and Rad. Total amount of insulin receptor expression was significantly higher in omental adipose tissue. Most of this increase was accounted for by expression of the differentially spliced insulin receptor lacking exon 11, which is considered to transmit the insulin signal less efficiently than the insulin receptor with exon 11. Perhaps consistent with a less efficient insulin signaling, a twofold reduction in GLUT4, glycogen synthase, and leptin mRNA expression was observed in omental adipose tissue. Finally peroxisome proliferator activated receptor-gamma (PPAR-gamma) mRNA levels were significantly lower in visceral adipose tissue in subjects with a BMI <30 kg/m2, but not in obese subjects, indicating that relative PPAR-gamma expression is increased in omental fat in obesity. This suggests that altered expression of PPAR-gamma might play a role in adipose tissue distribution and expansion.
Lefebvre
A M
AM
INSERM U.325, Département d'Athérosclérose, Institut Pasteur, Lille, France.
Laville
M
M
Vega
N
N
Riou
J P
JP
van Gaal
L
L
Auwerx
J
J
Vidal
H
H
D000273:Adipose Tissue / Q000737:chemistry / Q000378:metabolism* / Q000473:pathology*; D000328:Adult; D000368:Aged; D015992:Body Mass Index; D005091:Exons; D005260:Female; D005786:Gene Expression Regulation / Q000502:physiology; D015971:Gene Expression Regulation, Enzymologic / Q000502:physiology; D051275:Glucose Transporter Type 4; D006006:Glycogen Synthase / Q000032:analysis / Q000235:genetics; D006801:Humans; D020738:Leptin; D008049:Lipase / Q000032:analysis / Q000235:genetics; D008071:Lipoprotein Lipase / Q000032:analysis / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009004:Monosaccharide Transport Proteins / Q000032:analysis / Q000235:genetics; D009124:Muscle Proteins; D009765:Obesity / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D010732:Phosphofructokinase-1 / Q000032:analysis / Q000235:genetics; D016133:Polymerase Chain Reaction; D011506:Proteins / Q000032:analysis / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics / Q000378:metabolism*; D011972:Receptor, Insulin / Q000032:analysis / Q000235:genetics; D018160:Receptors, Cytoplasmic and Nuclear / Q000032:analysis / Q000235:genetics / Q000502:physiology; D014157:Transcription Factors / Q000032:analysis / Q000235:genetics / Q000502:physiology
D051275:Glucose Transporter Type 4; D020738:Leptin; D009004:Monosaccharide Transport Proteins; D009124:Muscle Proteins; D011506:Proteins; D012333:RNA, Messenger; D018160:Receptors, Cytoplasmic and Nuclear; C495692:SLC2A4 protein, human; D014157:Transcription Factors; D006006:Glycogen Synthase; D010732:Phosphofructokinase-1; D011972:Receptor, Insulin; D008049:Lipase; D008071:Lipoprotein Lipase